609 related articles for article (PubMed ID: 22852999)
1. Zygomycosis over-infection during voriconazole therapy for aspergillosis in a heart transplant patient, successfully treated with liposomal amphotericin and posaconazole.
Bourke P; Castro P; Rabagliati R; Beltran C; Verdejo H; Winter JL; Bourge RC
Transpl Infect Dis; 2012 Oct; 14(5):E56-9. PubMed ID: 22852999
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of pulmonary zygomycosis in two transplant recipients with liposomal amphotericin B and partial surgical resection followed by posaconazole.
Cooke DT; Pagani FD; Kaul DR; Cooke KR; Lau CL; Riddell J
Mycoses; 2010 Mar; 53(2):163-7. PubMed ID: 19207843
[No Abstract] [Full Text] [Related]
3. Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies.
Valentini CG; Candoni A; Fianchi L; Posteraro B; Simeone E; Costa F; Sanguinetti M; Voso MT; Caira M; Fanin R; Pagano L
Mycoses; 2010 Jan; 53(1):89-92. PubMed ID: 19207832
[TBL] [Abstract][Full Text] [Related]
4. [Invasive zygomycosis in patients treated for haematological malignancies].
Verweij PE; van der Velden WJ; Donnelly JP; Blijlevens NM; Warris A
Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2597-602. PubMed ID: 18161258
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of rhinocerebral zygomycosis with a combination of caspofungin and liposomal amphotericin B.
Vazquez L; Mateos JJ; Sanz-Rodriguez C; Perez E; Caballero D; San Miguel JF
Haematologica; 2005 Dec; 90(12 Suppl):ECR39. PubMed ID: 16464754
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous zygomycosis.
Bonifaz A; Vázquez-González D; Tirado-Sánchez A; Ponce-Olivera RM
Clin Dermatol; 2012; 30(4):413-9. PubMed ID: 22682190
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole.
Paul S; Marty FM; Colson YL
Ann Thorac Surg; 2006 Jul; 82(1):338-40. PubMed ID: 16798251
[TBL] [Abstract][Full Text] [Related]
8. Combination antifungal therapy for invasive pulmonary aspergillosis in a heart transplant recipient.
Beiras-Fernandez A; Bigdeli AK; Nickel T; Michel S; Ueberfuhr P; Reichart B; Kaczmarek I
Exp Clin Transplant; 2011 Aug; 9(4):279-83. PubMed ID: 21819376
[TBL] [Abstract][Full Text] [Related]
9. Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole.
Tsiodras S; Zafiropoulou R; Giotakis J; Imbrios G; Antoniades A; Manesis EK
Transpl Infect Dis; 2004 Mar; 6(1):37-40. PubMed ID: 15225226
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous zygomycosis caused by Saksenaea vasiformis following water-related wound in a 24-year-old immunocompetent woman.
Stewardson AJ; Holmes NE; Ellis DH; Howden BP
Mycoses; 2009 Nov; 52(6):547-9. PubMed ID: 19682315
[TBL] [Abstract][Full Text] [Related]
11. Treatment of invasive fungal sinusitis with liposomal amphotericin B: a report of four cases.
Sungkanuparph S; Sathapatayavongs B; Kunachak S; Luxameechanporn T; Cheewaruangroj W
J Med Assoc Thai; 2001 Apr; 84(4):593-601. PubMed ID: 11460976
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease.
Verma A; Williams S; Trifilio S; Zembower T; Mehta J
Bone Marrow Transplant; 2004 May; 33(10):1065-6. PubMed ID: 15048146
[No Abstract] [Full Text] [Related]
13. [Pulmonary zygomycosis in a patient treated for invasive aspergillosis].
Tricot S; Gastine T; Sendid B; Wurtz A; de Botton S; Alfandari S
Med Mal Infect; 2006 Feb; 36(2):118-21. PubMed ID: 16458464
[TBL] [Abstract][Full Text] [Related]
14. Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation.
Wieland T; Liebold A; Jagiello M; Retzl G; Birnbaum DE
J Heart Lung Transplant; 2005 Jan; 24(1):102-4. PubMed ID: 15653389
[TBL] [Abstract][Full Text] [Related]
15. Treatment of zygomycosis: current and new options.
Rogers TR
J Antimicrob Chemother; 2008 Jan; 61 Suppl 1():i35-40. PubMed ID: 18063603
[TBL] [Abstract][Full Text] [Related]
16. Use of newer antifungal therapies in clinical practice: what do the data tell us?
Perfect JR
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):15-23. PubMed ID: 15651178
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
[TBL] [Abstract][Full Text] [Related]
18. Successful management of rhinosinusal zygomycosis in a renal transplant recipient.
Gallet P; Debourgogne A; Rivier A; Marcon N; Georgel T; Ladrière M; Vignaud JM; Jankowski R; Machouart M
Mycoses; 2011 Sep; 54(5):e593-8. PubMed ID: 20524984
[No Abstract] [Full Text] [Related]
19. Current experience in treating invasive zygomycosis with posaconazole.
Cornely OA; Vehreschild JJ; Rüping MJ
Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():77-81. PubMed ID: 19754763
[TBL] [Abstract][Full Text] [Related]
20. An increasing trend of cutaneous zygomycosis caused by Mycocladus corymbifer (formerly Absidia corymbifera): report of two cases and review of primary cutaneous Mycocladus infections.
Almaslamani M; Taj-Aldeen SJ; Garcia-Hermoso D; Dannaoui E; Alsoub H; Alkhal A
Med Mycol; 2009; 47(5):532-8. PubMed ID: 19184768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
